Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients
- PMID: 22504106
- DOI: 10.1016/j.yexmp.2012.04.001
Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients
Abstract
Background: Malignant pleural mesothelioma (MPM) is a highly aggressive disease with a generally poor prognosis. Since escape from cell cycle checkpoint control is common in several solid tumors, the present study was performed to evaluate the role of some cell cycle regulatory genes in the development and progression of MPM.
Patients and methods: Aberrant expression of p14(ARF), p16(INK4A), p21(waf), p27(KIP), p53, mdm2 and Rb was assessed in 55 MPM cases from Egypt using immunohistochemistry and PCR techniques. Results were correlated with clinico-pathological prognostic factors, overall and disease free survival (OS&DFS).
Results: Altered expression of p14(ARF), p16(INK4A), p21(waf), p27(KIP1), Rb, p53 and mdm2 proteins was detected in 50.9%, 54.5%, 53.3%, 61.8%, 53.3%, 58.2%, and 50.8% of cases, respectively. SV40 infection significantly correlated with p14(ARF), 16(INK4A), p27(kip1) and Rb aberrations (p=0.014, p=0.02, p=0.01, p=-0.01). Asbestos exposure significantly correlated with p53, p21(waf) and mdm2 aberrations (p=0.001, p=0.03, p=0.02). On multivariate analysis PS ≥ 2, p27(KIP1) and Rb aberrations were independent prognostic factors for OS (p=0.016, p=0.011, p=0.003) whereas on tumor recurrence, p27(KIP1) and Rb aberrations were independent prognostic factors for DFS (p=0.002, p=0.03, p=0.01).
Conclusions: MPM is a complex disease characterized by multiple genetic aberrations; some of them involve cell cycle regulatory genes. p14(ARF), p16(INK4A), Rb and p27(KIP1) seem to be involved in SV40-associated MPM whereas mdm2, p53 and p21(WAF) are related to asbestos exposure. In addition to recurrence and PS, only p27(KIP1)and Rb could be used as molecular prognostic markers in MPM.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.Br J Cancer. 2015 Mar 3;112(5):883-90. doi: 10.1038/bjc.2015.27. Epub 2015 Feb 10. Br J Cancer. 2015. PMID: 25668009 Free PMC article.
-
Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma.Pathol Int. 2007 Aug;57(8):493-501. doi: 10.1111/j.1440-1827.2007.02130.x. Pathol Int. 2007. PMID: 17610473
-
Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.Hum Pathol. 2006 Jun;37(6):648-55. doi: 10.1016/j.humpath.2006.01.023. Hum Pathol. 2006. PMID: 16733203
-
Malignant pleural mesothelioma: factors influencing the prognosis.Oncology (Williston Park). 2012 Dec;26(12):1164-75. Oncology (Williston Park). 2012. PMID: 23413596 Review.
-
Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development.Lancet Oncol. 2004 Jun;5(6):354-62. doi: 10.1016/S1470-2045(04)01492-5. Lancet Oncol. 2004. PMID: 15172356 Review.
Cited by
-
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment.Front Oncol. 2021 Mar 22;11:653497. doi: 10.3389/fonc.2021.653497. eCollection 2021. Front Oncol. 2021. PMID: 33828993 Free PMC article.
-
MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.Br J Cancer. 2015 Mar 3;112(5):883-90. doi: 10.1038/bjc.2015.27. Epub 2015 Feb 10. Br J Cancer. 2015. PMID: 25668009 Free PMC article.
-
Prognostic Value of Ki67 Percentage, WT-1 Expression and p16/CDKN2A Deletion in Diffuse Malignant Peritoneal Mesothelioma: A Single-Centre Cohort Study.Diagnostics (Basel). 2020 Jun 9;10(6):386. doi: 10.3390/diagnostics10060386. Diagnostics (Basel). 2020. PMID: 32526924 Free PMC article.
-
Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients.Br J Cancer. 2015 Jun 30;113(1):69-75. doi: 10.1038/bjc.2015.187. Epub 2015 Jun 9. Br J Cancer. 2015. PMID: 26057448 Free PMC article.
-
CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.BMC Cancer. 2019 May 28;19(1):507. doi: 10.1186/s12885-019-5652-y. BMC Cancer. 2019. PMID: 31138176 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous